Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence

Pernille Holmager; Gro Linno Willemoe; Kåre  Nielsen; Veronica Grøndahl; Mikkel Andreassen; Seppo Wang Langer; Camilla P Hansen; Andreas Kjær; Birgitte Hartnack Federspiel; Ulrich Knigge

Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence

Pernille Holmager, Gro Linno Willemoe, Kåre Nielsen, Veronica Grøndahl, Mikkel Andreassen, Seppo Wang Langer, Camilla P Hansen, Andreas Kjær, Birgitte Hartnack Federspiel, Ulrich Knigge

Abstract

Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of 0.15–0.6/100,000/year

Aim(s): To characterize a cohort of 251 appendiceal NEN and to evaluate the risk of relapse.

Materials and methods: Prospective collection of data from 251 patients referred to Rigshospitalet 2000-2017, Goblet cell tumors excluded. Follow-up was possible by the patient’s security number and the Danish National Pathology Data Registry. No patients were lost to follow-up.

Original language	English
Publication date	2018
Publication status	Published - 2018
Event	15th Annual ENETS conference (2018) - Barcelon, Spain Duration: 7 Mar 2018 → 9 Mar 2018

Conference

Conference	15th Annual ENETS conference (2018)
Country/Territory	Spain
City	Barcelon
Period	07/03/2018 → 09/03/2018

Cite this

Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence. / Holmager, Pernille ; Willemoe, Gro Linno; Nielsen, Kåre et al.

2018. Abstract from 15th Annual ENETS conference (2018), Barcelon, Spain.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

@conference{8428d75d53f34fafabed49a5b3f9ba5e,

title = "Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence",

abstract = "Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of 0.15–0.6/100,000/year Aim(s): To characterize a cohort of 251 appendiceal NEN and to evaluate the risk of relapse. Materials and methods: Prospective collection of data from 251 patients referred to Rigshospitalet 2000-2017, Goblet cell tumors excluded. Follow-up was possible by the patient{\textquoteright}s security number and the Danish National Pathology Data Registry. No patients were lost to follow-up.",

author = "Pernille Holmager and Willemoe, {Gro Linno} and K{\aa}re Nielsen and Veronica Gr{\o}ndahl and Mikkel Andreassen and Langer, {Seppo Wang} and Hansen, {Camilla P} and Andreas Kj{\ae}r and Federspiel, {Birgitte Hartnack} and Ulrich Knigge",

year = "2018",

language = "English",

note = "15th Annual ENETS conference (2018) ; Conference date: 07-03-2018 Through 09-03-2018",

}

TY - ABST

T1 - Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence

AU - Holmager, Pernille

AU - Willemoe, Gro Linno

AU - Nielsen, Kåre

AU - Grøndahl, Veronica

AU - Andreassen, Mikkel

AU - Langer, Seppo Wang

AU - Hansen, Camilla P

AU - Kjær, Andreas

AU - Federspiel, Birgitte Hartnack

AU - Knigge, Ulrich

PY - 2018

Y1 - 2018

N2 - Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of 0.15–0.6/100,000/year Aim(s): To characterize a cohort of 251 appendiceal NEN and to evaluate the risk of relapse. Materials and methods: Prospective collection of data from 251 patients referred to Rigshospitalet 2000-2017, Goblet cell tumors excluded. Follow-up was possible by the patient’s security number and the Danish National Pathology Data Registry. No patients were lost to follow-up.

AB - Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of 0.15–0.6/100,000/year Aim(s): To characterize a cohort of 251 appendiceal NEN and to evaluate the risk of relapse. Materials and methods: Prospective collection of data from 251 patients referred to Rigshospitalet 2000-2017, Goblet cell tumors excluded. Follow-up was possible by the patient’s security number and the Danish National Pathology Data Registry. No patients were lost to follow-up.

M3 - Conference abstract for conference

T2 - 15th Annual ENETS conference (2018)

Y2 - 7 March 2018 through 9 March 2018

ER -

Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence

Abstract

Conference

Fingerprint

Cite this